Literature DB >> 14721799

Totally minimized extracorporeal circulation: an important benefit for coronary artery bypass grafting in Jehovah's witnesses.

Claude Vaislic1, Olivier Bical, Claude Farge, Didier Gaillard, Olivier Ponzio, Yves Ollivier, Youcef Abdelmoumen, Bruno Robine, Gérard Souffrant, Touami Bouharaoua.   

Abstract

BACKGROUND: Jehovah's Witnesses who require cardiac surgery represent a challenge to the physician because of their refusal to accept blood transfusions. Because coronary artery bypass grafting (CABG) is performed by most surgeons under cardiopulmonary bypass (CPB), which has potentially deleterious effects on hemostasis, we used a new concept called minimal extracorporeal circulation (MECC). MECC includes heparin-coated tubing, a centrifugal pump, and an oxygenator. There is no venous reservoir or vent, and suction is used through the cell saver. We assessed the hypothesis that MECC in combination with low-volume blood cardioplegia preserves more hemoglobin than conventional CPB in standard CABG.
METHODS: In 40 patients of the Jehovah's Witnesses faith undergoing CABG with the use of MECC and intermittent warm blood cardioplegia, clinical and biological data as well as values for parameters of hemolysis (plasma hemoglobin) and myocardial damage (troponin T) were determined. The results were compared with those of a control group of 40 patients who underwent operations with standard CPB.
RESULTS: Demographics, hemodynamics, the number of anastomoses, and CPB and cross-clamp times were comparable between the groups. MECC patients demonstrated significantly lower peak levels of plasma hemoglobin (21.8 +/- 114 mg/dL versus 35.4 +/- 15 mg/dL) and troponin T (0.12 +/- 0.4 ng/mL versus 0.65 +/- 0.7 ng/mL), a higher minimum hematocrit level during CPB (30% +/- 7% versus 23% +/- 6%), and a higher hemoglobin level 2 days after surgery (13 +/- 3 g/100 mL versus 9.4 +/- 0.98 g/100 mL). Preoperative values were not significantly different.
CONCLUSION: The use of MECC instead of conventional CPB reduces hemolysis, hemodilution, blood loss, and myocardial damage.

Entities:  

Mesh:

Year:  2003        PMID: 14721799

Source DB:  PubMed          Journal:  Heart Surg Forum        ISSN: 1098-3511            Impact factor:   0.676


  2 in total

1.  Outcomes in cardiac surgery in 500 consecutive Jehovah's Witness patients: 21 year experience.

Authors:  Claude D Vaislic; Nicolas Dalibon; Oliver Ponzio; Maguette Ba; Eric Jugan; Franck Lagneau; Philippe Abbas; Yves Olliver; Didier Gaillard; Francois Baget; Michel Sportiche; Antoine Chedid; Georges Chaoul; Philippe Maribas; Christiane Dupuy; Bruno Robine; Nicolas Kasanin; Herve Michon; Jean-Michel Ruat; Michel Habis; Touhami Bouharaoua
Journal:  J Cardiothorac Surg       Date:  2012-09-27       Impact factor: 1.637

Review 2.  Outcomes of cardiac surgery in Jehovah's Witness patients: A review.

Authors:  Aimee-Louise Chambault; Louise J Brown; Sophie Mellor; Amer Harky
Journal:  Perfusion       Date:  2020-12-16       Impact factor: 1.972

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.